UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Grows Position in Global Medical REIT Inc. (NYSE:GMRE)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in shares of Global Medical REIT Inc. (NYSE:GMRE) by 158.6% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 120,614 shares of the company’s stock after buying an additional 73,965 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.18% of Global Medical REIT worth $1,195,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds have also recently bought and sold shares of GMRE. Gordian Capital Singapore Pte Ltd bought a new position in shares of Global Medical REIT during the second quarter worth about $100,000. Intech Investment Management LLC acquired a new position in Global Medical REIT during the 3rd quarter valued at about $150,000. Versor Investments LP acquired a new position in shares of Global Medical REIT during the 3rd quarter valued at $189,000. M&G PLC bought a new stake in Global Medical REIT in the third quarter worth about $193,000. Finally, First Trust Direct Indexing L.P. boosted its stake in shares of Global Medical REIT by 25.6% during the 3rd quarter. First Trust Direct Indexing L.P. now owns 20,432 shares of the company’s stock worth $202,000 after acquiring an additional 4,164 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Global Medical REIT Price Performance

Shares of GMRE opened at $8.46 on Wednesday. The stock has a market cap of $565.15 million, a PE ratio of -423.00, a PEG ratio of 1.47 and a beta of 1.21. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The business has a 50-day simple moving average of $8.96 and a two-hundred day simple moving average of $9.21. Global Medical REIT Inc. has a 12-month low of $7.98 and a 12-month high of $11.59.

Global Medical REIT (NYSE:GMRE) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.21 by ($0.18). The firm had revenue of $34.26 million during the quarter, compared to analysts’ expectations of $34.88 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. During the same quarter in the previous year, the company posted $0.23 EPS. Analysts anticipate that Global Medical REIT Inc. will post 0.83 earnings per share for the current fiscal year.

Global Medical REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 8th. Investors of record on Friday, December 20th will be given a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 9.93%. The ex-dividend date is Friday, December 20th. Global Medical REIT’s dividend payout ratio (DPR) is presently -4,200.00%.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on GMRE. Berenberg Bank initiated coverage on shares of Global Medical REIT in a research note on Friday, October 18th. They set a “buy” rating and a $11.75 target price for the company. Alliance Global Partners initiated coverage on Global Medical REIT in a research report on Thursday, September 19th. They set a “buy” rating and a $12.00 target price on the stock.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.